Event Title: 12th Global Summit on Diabetes & Endocrinology
Dates: July 26-28, 2025
Venue: Holiday Inn Express Arena Towers, Amsterdam, Netherlands
Organized by: Inovine Scientific Meetings
Format: Hybrid Event

Overview

The 12th Global Summit on Diabetes & Endocrinology 2025 brought together clinicians, researchers, and healthcare professionals from across the world to share insights on diabetes management, endocrinology innovations, and metabolic health challenges. The three-day event featured keynote lectures, oral and poster presentations, and interactive panel discussions.

Day 1 Highlights - July 26, 2025

Session Chairs: Dr. Ravi Muppirala & Dr. G. Naresh Kumar (Jeeva Therapeutics, USA)

Keynote Sessions:

• Dr. Ravi Muppirala, Jeeva Therapeutics, USA
  “What should be the therapeutic target in the treatment of Type-2 Diabetes”
   
• Dr. G. Naresh Kumar, Jeeva Therapeutics, USA
  “Missing links in the aetiology and progression of Type-2 Diabetes”

Oral Presentations Included:

• Milena Raffi, University of Bologna, Italy
  “Exercise-induced changes in postural stability among patients with diabetes”
• Rania Alnounou, London Consulting Medical Center, UAE
  “Incretin Drugs for Diabetes Management”
• Lauri Deane, Time in Range Diabetes Education, USA
  “Early Screening of Type-1 Diabetes”
• Fatima Gamil Mohammed Sulaiman, MBR University, UAE
  “Profiling of circulating microRNA in different subtypes of Type 2 Diabetes in the Emirati Population”
• Hanaa Tarek El-Zawawy, American Hospital Dubai, UAE
  “Subclinical hypothyroidism: To treat or not to treat”
• Emna Hariz, KIT Institute, Netherlands
  “Knowledge, Attitudes, and Practices of Sports Instructors Regarding Type 1 Diabetes”

Poster Sessions:

• Benfiala Mouna, Central Army Hospital, Algeria
  Challenges and Strategies in Type 1 Polyendocrinopathy
• Duaa Ahmed Elhag, Sidra Medicine, Qatar
  MIRNA Expression Profile in Women with Gestational Diabetes

Day 2 Highlights - July 27, 2025

Oral Sessions Featured:

• Nazir Ahmad, Abasyn University, Pakistan
  Unlocking Okara’s Potential: A Plant-Based Approach to Managing Diabetes
• Mariya Tabassum, Abdul Malek Ukil Medical College, Bangladesh
  Non-pharmacological and Pharmacological Approaches to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
• Raffaele Pilla, St. John of God Hospital, Italy
  Therapeutic Ketosis and Applications for the Ketogenic Diet
• Saurabh Gupta, Pacific Medical College, India
  Clinical Significance of Second to Fourth Digit Ratio in Infertile Males

Panel Discussion: Open dialogue on innovations in diabetes research, endocrinology therapeutics, and collaborative care models.

Scientific Contributions

Over 40 scientific abstracts were presented across keynote, oral, and poster sessions. The summit emphasized:

• Novel biomarkers and genetic insights into diabetes.
• Advances in incretin-based and ketogenic therapies.
• Integrative and lifestyle-based diabetes interventions.
• Metabolic liver disease research and treatment paradigms.

Conclusion

The 12th Global Summit on Diabetes & Endocrinology 2025 successfully facilitated the exchange of cutting-edge knowledge, multidisciplinary collaboration and future research directions in endocrinology and metabolic disorders. The event concluded with a panel discussion and certificate felicitation ceremony, marking another milestone for Inovine Scientific Meetings.

The 10th World Congress on Diabetes & Endocrinology, organized by Inovine Meetings LLC, was held on June 09-10, 2025, in Zurich, Switzerland. The event brought together leading clinicians, researchers, endocrinologists, and healthcare professionals to discuss the latest advancements in diabetes management, endocrine disorders, and metabolic research.

Scientific Highlights (Day 1 – June 9, 2025, Virtual Session)

Oral Presentations

The session commenced at 09:00 AM with a series of insightful talks:

1. Dr. Tariq Hayat (UK)
   “Comparison of the Effect of Dapagliflozin and Empagliflozin on HbA1C and Renal Functions in Type 2 Diabetes Patients on Insulin Therapy”
   Presented comparative data showing glycemic and renal outcomes in SGLT2 inhibitor therapies.

2. Dr. Rahul Vaghasiya (Government Medical College, India)
   “Determination of SRPA and Adiposity Measures and Its Association with Glycemic Status in Type 2 Diabetics with High Mean HbA1c”
   Highlighted the correlation between adiposity indicators and poor glycemic control.

3. Arshbir Kaur (Punjabi University, India)
   “Computational Analysis of Overlapping Gene Signatures in Epilepsy and Type 2 Diabetes Mellitus”
   Explored shared molecular pathways, suggesting therapeutic overlap.

4. Bashayr Alsuwayni (King Saud University, Saudi Arabia)
   “Expanding the Pharmacist’s Role in Preventive Medicine Within Diabetes Clinics in Saudi Arabia”
   Advocated for enhanced pharmacist involvement in diabetes prevention and care.

5. Omar Abusedera (RCSI, Bahrain)
   “The Impact of Metformin on Pancreatic Cancer Risk and Prognosis: An Umbrella Review”
   Summarized meta-analyses showing metformin’s potential protective effects.

6. Abdelaziz Elmadani (Brooklyn College, UK)
   “Chronic Stress Responses in the Brain and Body Weaken the Immune System”
   Discussed the psychoneuroendocrine implications of chronic stress in metabolic disorders.

7. Al-Jazarie U. Masacal (Amai Pakpak Medical Center, Philippines)
   “Knowledge of Gestational Diabetes Mellitus Among Pregnant Women in a Tertiary Hospital in Marawi City”
   Evaluated awareness levels and suggested educational interventions for better maternal outcomes.

8. Hasan Avcu (Tesu Health Ltd., UK)
   “A Randomised Clinical Trial to Evaluate a Digital Therapeutic (PreDiaWell®) to Improve Glycaemic Control in Adults with Pre-diabetes”
   Reported promising results from digital health interventions for early-stage diabetes management.

Panel Discussion

The session concluded with a dynamic panel discussion where experts debated digital health integration, preventive endocrinology, and personalized diabetes therapy.

Key Takeaways

• SGLT2 inhibitors continue to show renal and cardiovascular benefits.

• Digital therapeutics are emerging as practical adjuncts in diabetes prevention.

• Pharmacist-led models can improve preventive care outcomes.

• Stress management and patient education remain critical in comprehensive diabetes control.

Acknowledgments

The organizing committee thanks all speakers, participants, and institutions for contributing to a successful scientific dialogue and for advancing diabetes and endocrinology research worldwide.

9th Global Summit on Diabetes & Endocrinology
August 14-16, 2024 | IntercityHotel Zurich Airport, Switzerland
Organized by: Inovine Scientific Meetings
Conference Mode: Hybrid

Conference Overview

The 9th Global Summit on Diabetes & Endocrinology 2024 was successfully organized in Zurich, Switzerland, bringing together eminent researchers, clinicians, healthcare professionals, and academicians from around the world. The summit served as an interactive forum for discussing innovative strategies, current advancements, and emerging trends in diabetes care, endocrinology, and metabolic disorders.

The event featured keynote speeches, oral and poster presentations, panel discussions, and networking sessions focused on bridging the gap between research and clinical practice.

Day 1 Highlights

Session Chair: Prof. Joachman Neumann, Martin-Luther-University Halle-Wittenberg, Germany

Keynote Presentations

• Dian True - Community Education & Wellness Partners, USA
  Topic: Diabetes Eye Care in Pregnancy
• Dr. Paul Aoun - American Hospital Dubai, UAE
  Topic: Diabetes Care Model: By Changing Nothing, Nothing Will Change

Scientific Presentations

• Dr. Sanam Lathief - Mount Auburn Hospital, Harvard Medical School, USA
  Topic: SGLT-2 Inhibitors, 2024 Update
• Prof. Joachman Neumann - Martin-Luther-University, Germany
  Topic: Positive Inotropic Effects of Retatrutide in the Isolated Human Atrium
• Dr. Patrick T. Fueger - Beckman Research Institute, City of Hope, USA
  Topic: Preventing MASLD/MASH Progression by Deleting Hepatic Mig6
• Dr. Arwa Alageel - King Saud University, Saudi Arabia
  Topic: Role of Non-exonic Variants in CALPAIN 10 Gene in PCOS Patients
• Dr. Warles Charles Lwabukuna - Hubert Kairuki Memorial University, Tanzania
  Topic: Profile of Fasting Blood Glucose Among Secondary School Students in Dar Es Salaam
• Dr. Arbind Kumar - AIIMS Raebareli, India
  Topic: Impact of Early and Late Diagnosis of Type 2 Diabetes on Cognitive Function
• Dr. Aljohrah Aldubikhi - Saudi Electronic University, Saudi Arabia
  Topic: Effect of Health Educators on Diabetes Control

Poster Presentations

• Dr. Mosleh Abomughaid - University of Bisha, Saudi Arabia
  Topic: Antidiabetic Activity and Phytochemical Profiling of Ajuga iva
• Dr. Suhaila Abdalkarim Ali Fadol - Jazan University, Saudi Arabia
  Topic: Association of Anxiety and Depressive Symptoms and Treatment Adherence Among Diabetic Patients

Day 2 Highlights

Virtual Presentations (Zoom - UK Time Zone)

• Dr. Donghong Gaoa - University at Albany, USA
  Topic: Ultrafine Particles and Cold Exposure Effects on Diabetes Hospitalizations
• Dr. Kaisun Nesa Lesa - Khulna University, Bangladesh
  Topic: Functional Food for Type 2 Diabetes Mellitus: Okara Noodles
• Dr. Meagan Horne - Houston Methodist Hospital, USA
  Topic: Food Insecurity and Diabetes in the United States
• Dr. Yuosra A. Ali - University of Mosul, Iraq
  Topic: Evaluation of Vegetable Oils Used in Potato Chips Production in Mosul
• Dr. Shaima Albeloushi - Dasman Diabetes Institute, Kuwait
  Topic: Comparative Effects of Fish Oil and Cocoa Butter Diets on IL-1β Expression in β-cells
• Dr. Marilena Stoian - Carol Davila University of Medicine, Romania
  Topic: Nephrotic Syndrome in Diabetic Patients Not Always Linked to Diabetic Nephropathy
• Dr. Rosa G. Zamarripa-Jáuregui - Instituto Mexicano del Seguro Social, Mexico
  Topic: Marine-Lenhart Syndrome: Case Report
• Dr. Aida Kabibulatova - Nazarbayev University, Kazakhstan
  Topic: Vitamin D Receptor Gene Polymorphism in Diabetic Kidney Disease
• Dr. Nazir Ahmad - Universitas Gadjah Mada, Indonesia
  Topic: Protective Role of Okra Against Diabetes and Cognitive Decline
• Dr. Abdul Hameed - Ziauddin University, Pakistan
  Topic: Hispidulin as an Insulin Secretagogue via AKAP9-mediated PKA Pathway
• Dr. Giuseppina Lagana - University of Messina, Italy
  Topic: Influence of Catechins and Proanthocyanidins on Insulin Resistance and Diabetes

Conference Outcomes

The 9th Global Summit on Diabetes & Endocrinology 2024 achieved significant outcomes, including:

• Fostering global research collaborations in diabetes and endocrine studies.
• Promoting advances in clinical endocrinology and metabolic research.
• Encouraging student and researcher engagement through poster and oral presentation awards.
• Enabling cross-disciplinary exchange between basic scientists, clinicians, and public health experts.

The event concluded with a panel discussion and certificate distribution ceremony.

Acknowledgment

Inovine Scientific Meetings extends heartfelt thanks to all speakers, delegates, session chairs and sponsors for their valuable contributions to making this event a grand success.

Title: 8th Global Summit on Diabetes & Obesity

Organizer: Inovine Scientific Meetings

Dates: July 29-31, 2024

Venue: Hyatt Place London Heathrow Airport, UK

Format: Hybrid Event

The conference brought together endocrinologists, diabetologists, nutrition experts, and medical researchers from more than 20 countries to discuss the latest developments in diabetes and obesity prevention, management, and therapeutics.

Conference Highlights

Day 1 - July 29, 2024 (Physical Sessions)

Session Chair: Therese Mary Cameron (Diabetes Alliance, Australia)

Keynote Presentations:

Therese Mary Cameron (Australia) – Cultural Impacts on Propensity for Obesity
Examined cultural dietary habits and their correlation with obesity rates in indigenous and immigrant communities.

Samir Kumar Talukdar (Bangladesh) – Integrated Approaches to Diabetes and Obesity Management
Discussed physiological and lifestyle-based interventions, including GLP-1 receptor agonists and the novel Tirzepatide.

Speaker Highlights:

Md. Masud Un Nabi (Bangladesh): Therapeutic Inertia to Insulin Therapy - Magnitude & Solution”

Shweta Arora (India): Lifestyle Habits and Type 2 Diabetes in Indian Population

Panagiotis Rigopoulos & Apostolos Stratopoulos (Greece): Economic Value of Preventing Morbidity & Mortality

Rania Alnounou (UAE): Incretin Drugs for Diabetes Management

Jhunior J. Gosalvez Sanchez (Bolivia): Advances in Pathophysiology and Therapeutic Innovations

Panjasaram Vassie Naidoo (South Africa): Diabetes in HIV-Infected Persons

Poster presentations focused on lifestyle modifications, diet, and metabolic research.

Panel Discussion and Certificate Distribution concluded Day 1.

Day 2 - July 30, 2024 (Virtual & Hybrid Sessions)

The second day featured Zoom-based virtual sessions accessible globally (GMT+1 timezone).

Virtual Key Presentations:

Ravi Muppirala (USA, Jeeva Therapeutics) – Therapeutic Targets in Type-2 Diabetes
Explored hyperinsulinemia and innovative approaches to mimic physiological insulin secretion.

G. Naresh Kumar (India, Jeeva Therapeutics) – Missing Links in the Etiology & Progression of Type 2 Diabetes
Highlighted the role of leaky gut, lipid metabolism, and inflammation in T2DM.

Meagan Horne (USA) – Food Insecurity and Diabetes in the United States
Discussed nutritional policy and access issues affecting diabetic populations.

Khalid Saifullah & Nurul Huda Likhon (Bangladesh) – Depression and Controlled vs. Uncontrolled Diabetes

Mariya Tabassum (Bangladesh): Comparing Novel Lipid Indices in Predicting Metabolic Syndrome

V. K. Sashindran (India): Low-Cost Health Strategies in Urban Slum Elderly Diabetics

Mohanad Mahdi Thumad Al-kaisey (Iraq): Cardiovascular Autonomic Neuropathy in Type II Diabetes

Hanaa Tarek El-Zawawy (UAE): Subclinical Hypothyroidism – To Treat or Not to Treat?

Anasuya Ganguly (India): Tissue Engineering and 3D Bioprinting in Diabetes Treatment

Virtual Engagement

The virtual segment enabled live presentations and interactive Q&A via Zoom, connecting global participants from Asia, the Middle East, Europe and the Americas. Each session included:

Live chat for question submissions.

Panel discussions moderated by the scientific committee.

E-certificates and E-book provided to online attendees.

Outcomes & Key Insights

Hybrid model improved accessibility and diversity of participation.

Major themes included genetic markers, incretin therapies, nutrigenomics, bioprinting, and public health strategies.

Consensus emphasized integrated prevention, mental health screening, and innovative pharmacological developments.

Conclusion

The 8th Global Summit on Diabetes & Obesity 2024 successfully bridged clinical, technological, and cultural insights through its hybrid format, fostering international collaboration in metabolic health research.